Related Experiment Video

Updated: Jul 9, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

An update on drug combinations for treatment of myeloma

Muralikrishnan Srikanth1, Faith E Davies, Gareth J Morgan

  • 1The Royal Marsden Hospital, Department of Haemato-Oncology, Downs Road, Sutton, Surrey SM2 5PT, UK.

Expert Opinion on Investigational Drugs
|December 22, 2007
PubMed

Insights

New biological therapies, including proteasome inhibitors and immunomodulatory drugs, are improving multiple myeloma treatment. Combination therapies show enhanced efficacy, offering a promising paradigm for managing this hematological malignancy.

Area of Science:

  • Hematological Malignancies
  • Cancer Drug Development
  • Immunotherapy

Background:

  • Multiple myeloma is a significant hematological malignancy with improving, yet still limited, long-term patient outcomes.
  • Conventional and high-dose chemotherapy offer management options, but novel therapeutic strategies are critically needed.
  • Existing treatments necessitate the development of new drugs and combinations to enhance efficacy.

Purpose of the Study:

  • To review the development and efficacy of novel biological therapies for multiple myeloma.
  • To highlight the role of targeted agents and combination therapies in improving patient outcomes.
  • To discuss the challenges and potential of new drug development in multiple myeloma.

Main Methods:

  • Review of current literature on novel agents in multiple myeloma treatment.
  • Analysis of the efficacy of single-agent and combination therapies, including bortezomib, thalidomide, and lenalidomide.
  • Discussion of emerging therapeutic pathways and their clinical trial evaluation.

Main Results:

  • Novel biological therapies, such as proteasome inhibitors (e.g., bortezomib) and immunomodulatory drugs (e.g., thalidomide, lenalidomide), demonstrate significant efficacy.
  • These agents show enhanced activity when used in combination compared to single-agent use.
  • Combination therapies targeting key myeloma pathogenic pathways offer a promising strategy, even for agents with limited single-agent activity.

Conclusions:

  • Novel targeted therapies and combination regimens are revolutionizing multiple myeloma management.
  • Combination strategies are crucial for overcoming treatment resistance and improving long-term outcomes.
  • The development of new drugs and clinical trial designs presents a paradigm for future cancer therapy.

More Related Videos

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...